Research Program: Breast & Ovary Cancers
研究项目:乳房
基本信息
- 批准号:10636835
- 负责人:
- 金额:$ 7.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:BRCA1 geneBRCA2 geneBreastBreast Cancer PreventionBreast Cancer survivorBreast Cancer therapyCancer Center Support GrantCatchment AreaCenter Core GrantsCessation of lifeClinicalCommunitiesDNADNA RepairDedicationsDefectDerivation procedureDetectionDiagnosisDirect CostsDiseaseERBB2 geneEarly DiagnosisExerciseFacultyFosteringFundingGenetic Predisposition to DiseaseGenetic RiskGrantHistologicHormonalIncidenceInstitutionInterdisciplinary StudyInterventionIonizing radiationLocalized Malignant NeoplasmMalignant NeoplasmsMalignant neoplasm of ovaryMammalian OviductsMismatch RepairMolecularMutationOncogenesOvaryPIK3CA genePaperPeer ReviewPeritoneumPlatinum CompoundsPoly(ADP-ribose) Polymerase InhibitorPopulationPredispositionPublishingReproductive BehaviorResearchResearch PersonnelResearch Project GrantsResearch SupportResistanceResource SharingResourcesRiskRisk AssessmentSecondary toSerousSurvivorsTherapeuticTissuesUniversitiesWashingtonWomanWorkcancer carecancer preventioncancer typecognitive rehabilitationhigh riskhomologous recombinationhormone receptor-negativeimprovedmalignant breast neoplasmmeetingsmembermolecular subtypesmortalityoverexpressionprogramsrare cancerrecruitresponsestress reductionsurvivorshiptargeted treatmenttherapeutic targettriple-negative invasive breast carcinoma
项目摘要
PROJECT SUMMARY: BREAST & OVARY CANCERS (BOC)
The Breast & Ovary Cancers (BOC) Program brings together a highly cross-disciplinary and collaborative
group of investigators dedicated to reducing the incidence and mortality of breast and ovary cancers. The
program fosters interdisciplinary research at Fred Hutch (FH), University of Washington (UW), Seattle Cancer
Care Alliance (SCCA), and in the community to improve cancer prevention, detection, diagnosis, and
treatment. The BOC Program is led by Drs. Nancy Davidson and Elizabeth Swisher, along with Associate
Program Leaders, Drs. Julie Gralow and Barbara Goff, who are leaders at the institutions described above.
The Program aims to (1) improve strategies to assess risk, identify, screen, and prevent breast and ovary
cancer in women, especially those at high risk and (2) develop targeted therapies for breast and ovary cancers
with a special focus on improving response and predicting resistance.
The BOC Program currently has 54 members with 11 based at Fred Hutch and 43 based at University of
Washington. The current research support of BOC members is $14.7M (direct costs), of which $8.8M is peer-
reviewed funding, including $3.5M from the NCI. BOC Program members published a total of 628 papers over
the current grant period, of which 20% were intra-programmatic, 28% were inter-programmatic, and 47% had
external co-authors. All 12 Consortium Shared Resources were utilized by BOC members in the course of their
work. This P30 grant also assists this program by providing administrative and logistical support for BOC
meetings, pilot funding for new research projects, and recruitment resources for new faculty.
项目摘要:乳腺癌和卵巢癌 (BOC)
乳腺癌和卵巢癌 (BOC) 项目汇集了高度跨学科和协作的团队
致力于降低乳腺癌和卵巢癌的发病率和死亡率的研究小组。这
项目促进 Fred Hutch (FH)、华盛顿大学 (UW)、西雅图癌症中心的跨学科研究
护理联盟 (SCCA),并在社区中改善癌症预防、检测、诊断和治疗
治疗。 BOC 计划由博士领导。南希·戴维森 (Nancy Davidson) 和伊丽莎白·斯威舍 (Elizabeth Swisher) 以及同事
项目负责人,博士。 Julie Gralow 和 Barbara Goff 是上述机构的领导者。
该计划旨在 (1) 改进评估风险、识别、筛查和预防乳腺癌和卵巢癌的策略
女性癌症,尤其是高危女性,以及 (2) 开发针对乳腺癌和卵巢癌的靶向疗法
特别关注改善反应和预测阻力。
BOC 项目目前有 54 名成员,其中 11 名来自 Fred Hutch,43 名来自 University of University。
华盛顿。目前 BOC 成员的研究支持为 1,470 万美元(直接成本),其中 880 万美元是同行费用
审查了资金,包括来自 NCI 的 350 万美元。 BOC项目成员共发表论文628篇
当前资助期,其中 20% 为计划内资助,28% 为计划间资助,47% 为计划间资助
外部合著者。所有 12 个联盟共享资源均由 BOC 成员在其业务过程中使用
工作。这笔 P30 赠款还通过为中国银行提供行政和后勤支持来协助该计划
会议、新研究项目的试点资金以及新教师的招聘资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cyrus M Ghajar其他文献
Cyrus M Ghajar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cyrus M Ghajar', 18)}}的其他基金
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
化疗驱动的血管分泌组进化及其在治疗抵抗中的作用
- 批准号:
10321289 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
化疗驱动的血管分泌组进化及其在治疗抵抗中的作用
- 批准号:
10601470 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance
化疗驱动的血管分泌组进化及其在治疗抵抗中的作用
- 批准号:
10544717 - 财政年份:2021
- 资助金额:
$ 7.62万 - 项目类别:
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
定义和表征脑中播散性肿瘤细胞休眠的微环境驱动因素
- 批准号:
10400671 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
定义和表征脑中播散性肿瘤细胞休眠的微环境驱动因素
- 批准号:
10685943 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
定义和表征脑中播散性肿瘤细胞休眠的微环境驱动因素
- 批准号:
10601281 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
定义和表征脑中播散性肿瘤细胞休眠的微环境驱动因素
- 批准号:
10158461 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain
定义和表征脑中播散性肿瘤细胞休眠的微环境驱动因素
- 批准号:
10037395 - 财政年份:2020
- 资助金额:
$ 7.62万 - 项目类别:
相似国自然基金
DNA同源重组基因EXO1和BRCA2在早发性卵巢功能不全发病中的作用和致病机制研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
BRCA2基因新突变导致的甲基缺失引起高危家族卵巢/乳腺癌发生的机制研究
- 批准号:81972444
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
中国家族性乳腺癌BRCA1/2基因大片段重排断裂位点鉴定及功能研究
- 批准号:81772824
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
BRCA2基因肿瘤抑制新机制:抑制中心体过度复制
- 批准号:30771110
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
BACP1-BRCA2相互作用及其有丝分裂调控的研究
- 批准号:30470370
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Detection of Emergent Mechanical Properties of Biologically Complex Cellular States
生物复杂细胞状态的紧急机械特性的检测
- 批准号:
10838854 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Synergize a novel homologous recombination inhibitor with DNA damagingagents in TNBC
在 TNBC 中协同新型同源重组抑制剂与 DNA 损伤剂
- 批准号:
10760604 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别:
Quantifying replication dynamics to predict clonal evolution and drug sensitivity in cancer cells using single-cell whole genome sequencing
使用单细胞全基因组测序量化复制动态以预测癌细胞的克隆进化和药物敏感性
- 批准号:
10603140 - 财政年份:2023
- 资助金额:
$ 7.62万 - 项目类别: